Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Pappas

Showing results (381-390 of 457) with videos related to

Pageof 46
Sort By:
Rheumatology and Therapy|October 31, 2023
Clinical Outcomes in Patients with Rheumatoid Arthritis After Switching Between Interleukin-6-Receptor Inhibitors and Janus Kinase Inhibitors: Findings from an Observational StudyAnisha B Dua, Kerri Ford, Stefano Fiore, et al.
Journal of the American Medical Directors Association|December 7, 2025
Hospitalization Experiences Among Nursing Home Residents With DementiaJordan M Alpert, Jeffrey D Kovach, Nicholas J Casacchia, et al.
Rheumatology and Therapy|May 28, 2021
Association Between Baseline Anti-cyclic Citrullinated Peptide Antibodies and 6-Month Clinical Response Following Abatacept or TNF Inhibitor Treatment: A Real-World Analysis of Biologic-Experienced Patients with RALeslie R Harrold, Joshua Bryson, Thomas Lehman, et al.
Annals of the Rheumatic Diseases|May 30, 2013
Association of fine specificity and repertoire expansion of anticitrullinated peptide antibodies with rheumatoid arthritis associated interstitial lung diseaseJon T Giles, Sonye K Danoff, Jeremy Sokolove, et al.
Annals of the Rheumatic Diseases|October 5, 2013
A weighted genetic risk score using all known susceptibility variants to estimate rheumatoid arthritis riskAnnie Yarwood, Buhm Han, Soumya Raychaudhuri, et al.
Rheumatology (Oxford, England)|November 8, 2021
Assessing predictors of rheumatoid arthritis-associated interstitial lung disease using quantitative lung densitometryMichail K Alevizos, Sonye K Danoff, Dimitrios A Pappas, et al.
The Journal of Trauma|February 13, 2004
Inter- and intrarater reliability in computed axial tomographic grading of splenic injury: why so many grading scales?Erik S Barquist, Louis R Pizano, William Feuer, et al.
Psychopharmacology|February 8, 2005
Involvement of adenosine A1 receptors in the discriminative-stimulus effects of caffeine in ratsMarcello Solinas, Sergi Ferré, Katerina Antoniou, et al.
Annals of the Rheumatic Diseases|November 12, 2020
Response to 'Correspondence on 'Comparative effectiveness of first-line tumour necrosis factor inhibitor versus non-tumour necrosis factor inhibitor biologics and targeted synthetic agents in patients with rheumatoid arthritis: results from a large US registry study'' by Zheng <i>et al</i>Dimitrios A Pappas, Gregory St John, Carol J Etzel, et al.
Annals of the Rheumatic Diseases|July 29, 2020
Comparative effectiveness of first-line tumour necrosis factor inhibitor versus non-tumour necrosis factor inhibitor biologics and targeted synthetic agents in patients with rheumatoid arthritis: results from a large US registry studyDimitrios A Pappas, Gregory St John, Carol J Etzel, et al.
Pageof 46

Showing results (381-390 of 457) with videos related to

Sort By:
Pageof 46
Rheumatology and Therapy|October 31, 2023
Clinical Outcomes in Patients with Rheumatoid Arthritis After Switching Between Interleukin-6-Receptor Inhibitors and Janus Kinase Inhibitors: Findings from an Observational StudyAnisha B Dua, Kerri Ford, Stefano Fiore, et al.
Journal of the American Medical Directors Association|December 7, 2025
Hospitalization Experiences Among Nursing Home Residents With DementiaJordan M Alpert, Jeffrey D Kovach, Nicholas J Casacchia, et al.
Rheumatology and Therapy|May 28, 2021
Association Between Baseline Anti-cyclic Citrullinated Peptide Antibodies and 6-Month Clinical Response Following Abatacept or TNF Inhibitor Treatment: A Real-World Analysis of Biologic-Experienced Patients with RALeslie R Harrold, Joshua Bryson, Thomas Lehman, et al.
Annals of the Rheumatic Diseases|May 30, 2013
Association of fine specificity and repertoire expansion of anticitrullinated peptide antibodies with rheumatoid arthritis associated interstitial lung diseaseJon T Giles, Sonye K Danoff, Jeremy Sokolove, et al.
Annals of the Rheumatic Diseases|October 5, 2013
A weighted genetic risk score using all known susceptibility variants to estimate rheumatoid arthritis riskAnnie Yarwood, Buhm Han, Soumya Raychaudhuri, et al.
Rheumatology (Oxford, England)|November 8, 2021
Assessing predictors of rheumatoid arthritis-associated interstitial lung disease using quantitative lung densitometryMichail K Alevizos, Sonye K Danoff, Dimitrios A Pappas, et al.
The Journal of Trauma|February 13, 2004
Inter- and intrarater reliability in computed axial tomographic grading of splenic injury: why so many grading scales?Erik S Barquist, Louis R Pizano, William Feuer, et al.
Psychopharmacology|February 8, 2005
Involvement of adenosine A1 receptors in the discriminative-stimulus effects of caffeine in ratsMarcello Solinas, Sergi Ferré, Katerina Antoniou, et al.
Annals of the Rheumatic Diseases|November 12, 2020
Response to 'Correspondence on 'Comparative effectiveness of first-line tumour necrosis factor inhibitor versus non-tumour necrosis factor inhibitor biologics and targeted synthetic agents in patients with rheumatoid arthritis: results from a large US registry study'' by Zheng <i>et al</i>Dimitrios A Pappas, Gregory St John, Carol J Etzel, et al.
Annals of the Rheumatic Diseases|July 29, 2020
Comparative effectiveness of first-line tumour necrosis factor inhibitor versus non-tumour necrosis factor inhibitor biologics and targeted synthetic agents in patients with rheumatoid arthritis: results from a large US registry studyDimitrios A Pappas, Gregory St John, Carol J Etzel, et al.
Pageof 46